Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy

Por Maya S. Graham, Ingo K. Mellinghoff
Publicado em 2020-09-01

A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.

Por Yu-Kang Cheng, Rameen Beroukhim, Ross L Levine, Ingo K Mellinghoff, Eric C Holland, Franziska Michor
Publicado em 2012-01-01

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions

Por Douglas A. Mata, Jamal K. Benhamida, Andrew L. Lin, Chad M. Vanderbilt, Soo-Ryum Yang, Liliana B. Villafania, Donna C. Ferguson, Philip Jonsson, Alexandra M. Miller, Viviane Tabar, Cameron W. Brennan, Nelson S. Moss, Martin Sill, Ryma Benayed, Ingo K. Mellinghoff, Marc K. Rosenblum, Maria E. Arcila, Marc Ladanyi, Tejus A. Bale
Publicado em 2020-11-01